Of note, although administration of IL-33 induced proliferation of both luminal surface BECs and PBGs, Ki67 staining revealed that IL-33 exerted greater effects on proliferation of PBGs when compared with surface BECs [12], suggesting that IL-33 may accelerate CCA development from PBGs. Here, IL33 is linked to cholangiocarcinoma.